Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00520104
Recruitment Status : Unknown
Verified August 2007 by Javelin Pharmaceuticals.
Recruitment status was:  Active, not recruiting
First Posted : August 23, 2007
Last Update Posted : February 29, 2008
Information provided by:
Javelin Pharmaceuticals

Brief Summary:
This is an open label, single-center study to determine whether certain nasal medication interact with PMI-150 (intranasal ketamine) 30 mg in healthy adult volunteers and in patients with allergic rhinitis.

Condition or disease Intervention/treatment Phase
Pharmacokinetics Drug: intranasal ketamine Phase 1

Detailed Description:
To assess separately the effects of a nasal vasoconstrictor (oxymetazoline) and of a nasal steroid on the rate and extent of intranasal absorption of PMI-150 30 mg.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 48 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized, Open Label, Single Center, Single-Dose Study to Assess the Effects of Certain Nasal Medications on the Pharmacokinetics, Safety and Tolerability of PMI-150 (Intranasal Ketamine Hydrochloride) 30 mg
Study Start Date : August 2007
Actual Primary Completion Date : February 2008
Estimated Study Completion Date : March 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Medicines
Drug Information available for: Ketamine

Arm Intervention/treatment
Experimental: A
intranasal ketamine
Drug: intranasal ketamine
drug interaction

Experimental: B
oxymetazoline plus intranasal ketamine
Drug: intranasal ketamine
drug interaction

Experimental: C
intranasal steroid plus intranasal ketamine
Drug: intranasal ketamine
drug interaction

Primary Outcome Measures :
  1. Pharmacokinetics [ Time Frame: multiple ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy adults
  • Patients with Allergic Rhinitis

Exclusion Criteria:

  • Under age 18

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00520104

Layout table for location information
United States, Massachusetts
Javelin Pharmaceuticals
Cambridge, Massachusetts, United States, 02140
Sponsors and Collaborators
Javelin Pharmaceuticals
Layout table for investigator information
Study Director: Javelin Pharmaceuticals Javelin Pharmaceuticals
Layout table for additonal information
Responsible Party: Javelin Pharmaceuticals Identifier: NCT00520104    
Other Study ID Numbers: KET-PK-008
First Posted: August 23, 2007    Key Record Dates
Last Update Posted: February 29, 2008
Last Verified: August 2007
Additional relevant MeSH terms:
Layout table for MeSH terms
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anesthetics, Dissociative
Anesthetics, Intravenous
Anesthetics, General
Central Nervous System Depressants
Excitatory Amino Acid Antagonists
Excitatory Amino Acid Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action